Korean biotech firm bought by Parataxis for Bitcoin treasury use
Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers.
Original Source
- The biggest blockchain upgrades still to come in 2026
- UK payments blueprint outlines tokenized payments for ‘multi-money ecosystem’
- Aave brings V3 lending and GHO stablecoin to Monad
- Standard Chartered, Circle bring USDC minting onto banking rails
- French banking giant Crédit Agricole launches EURXT euro stablecoin
- Bank of Korea governor outlines tokenized bond vision, unified ledger plan
- Circle CEO touts USDC’s network advantage as OUSD emerges
- Last-minute MiCA approvals mark end of EU transition period
- MetaMask launches stablecoin yield account with card spending
- OKX launches AI marketplace for autonomous agent economy